Indication
Organophosphorus Poisoning
2 clinical trials
4 products
Clinical trial
Outcome of OPC Poisoning Patients Between Two Treatment Groups One With Atropine Plus Pralidoxime and Other With Only AtropineStatus: Recruiting, Estimated PCD: 2024-10-01
Product
PralidoximeProduct
AtropineClinical trial
Role of Intralipid in Management of Organophosphorus PoisoningStatus: Not yet recruiting, Estimated PCD: 2025-11-01
Product
IntralipidProduct
Atropine Sulfate